Ironwood Pharma (NASDAQ: IRWD) reported Q2 EPS of $0.31, $0.07 worse than the analyst estimate of $0.38. Revenue for the quarter came in at $113.04 million versus the consensus estimate of $117.6 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.